Furthermore, Bonuccelli et al. showed in a breast cancer mouse model that Cav-1-deficient stromal fibroblasts upregulate the expression of glycolytic enzymes, a hallmark of the Warburg effect, and this may provide energy-rich metabolites in a paracrine fashion to the tumor cells, supporting the clinical findings in breast cancer [49]. This evidence concerns the gene CAV1 and breast cancer.